PL2376500T3 - Sól maleinianowa 11-(2-pirrolidyn-1-yloetoksy)-14,19-dioksa-5,7,26 triazatetracyklo[19.3.1.1(2,6).1(8,12)]heptakosa-1(25),2(26),3,5,8,10,12(27),16,21,23-dekaenu - Google Patents

Sól maleinianowa 11-(2-pirrolidyn-1-yloetoksy)-14,19-dioksa-5,7,26 triazatetracyklo[19.3.1.1(2,6).1(8,12)]heptakosa-1(25),2(26),3,5,8,10,12(27),16,21,23-dekaenu

Info

Publication number
PL2376500T3
PL2376500T3 PL09793626T PL09793626T PL2376500T3 PL 2376500 T3 PL2376500 T3 PL 2376500T3 PL 09793626 T PL09793626 T PL 09793626T PL 09793626 T PL09793626 T PL 09793626T PL 2376500 T3 PL2376500 T3 PL 2376500T3
Authority
PL
Poland
Prior art keywords
decaene
heptacosa
tetracyclo
triaza
dioxa
Prior art date
Application number
PL09793626T
Other languages
English (en)
Inventor
Brian Dymock
Cheng Hsia Angeline Lee
Anthony Deodaunia William
Original Assignee
Cti Biopharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cti Biopharma Corp filed Critical Cti Biopharma Corp
Publication of PL2376500T3 publication Critical patent/PL2376500T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL09793626T 2008-12-11 2009-12-09 Sól maleinianowa 11-(2-pirrolidyn-1-yloetoksy)-14,19-dioksa-5,7,26 triazatetracyklo[19.3.1.1(2,6).1(8,12)]heptakosa-1(25),2(26),3,5,8,10,12(27),16,21,23-dekaenu PL2376500T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12167608P 2008-12-11 2008-12-11
EP09793626.4A EP2376500B1 (en) 2008-12-11 2009-12-09 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt
PCT/SG2009/000474 WO2010068182A1 (en) 2008-12-11 2009-12-09 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene maleate salt

Publications (1)

Publication Number Publication Date
PL2376500T3 true PL2376500T3 (pl) 2015-07-31

Family

ID=42103945

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09793626T PL2376500T3 (pl) 2008-12-11 2009-12-09 Sól maleinianowa 11-(2-pirrolidyn-1-yloetoksy)-14,19-dioksa-5,7,26 triazatetracyklo[19.3.1.1(2,6).1(8,12)]heptakosa-1(25),2(26),3,5,8,10,12(27),16,21,23-dekaenu

Country Status (10)

Country Link
US (1) US8987243B2 (pl)
EP (1) EP2376500B1 (pl)
AR (2) AR074725A1 (pl)
DK (1) DK2376500T3 (pl)
ES (1) ES2536276T3 (pl)
HR (1) HRP20150413T8 (pl)
PL (1) PL2376500T3 (pl)
PT (1) PT2376500E (pl)
TW (1) TWI457342B (pl)
WO (1) WO2010068182A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8604042B2 (en) 2005-11-01 2013-12-10 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
MX362412B (es) 2005-11-01 2019-01-15 Targegen Inc Inhibidores de biaril meta-pirimidina de cinasas.
US8133900B2 (en) 2005-11-01 2012-03-13 Targegen, Inc. Use of bi-aryl meta-pyrimidine inhibitors of kinases
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12012501003B1 (en) * 2005-11-16 2018-04-06 Cti Biopharma Corp Oxygen linked pyrimidine derivatives
EP2376499B1 (en) * 2008-12-11 2015-02-25 Cti Biopharma Corp. 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt

Also Published As

Publication number Publication date
EP2376500B1 (en) 2015-02-25
TW201028425A (en) 2010-08-01
TWI457342B (zh) 2014-10-21
WO2010068182A1 (en) 2010-06-17
EP2376500A1 (en) 2011-10-19
US8987243B2 (en) 2015-03-24
ES2536276T3 (es) 2015-05-22
US20110263616A1 (en) 2011-10-27
DK2376500T3 (en) 2015-05-04
AR114134A2 (es) 2020-07-22
AR074725A1 (es) 2011-02-09
PT2376500E (pt) 2015-06-02
HRP20150413T1 (hr) 2015-07-03
HRP20150413T8 (xx) 2015-08-14

Similar Documents

Publication Publication Date Title
HUS1800031I1 (hu) Dioxa-biciklo[3.2.1.]oktán-2,3,4-triol származékok
PL2013208T3 (pl) Pirydyno[3,4-B]pirazynowy
ZA201001434B (en) 2-aza-bicyclo[3.3.0]octane derivatives
PL2044036T3 (pl) Pochodne [4,5']bipirymidynylo-6,4'-diaminy jako inhibitory kinaz białkowych
ZA201104706B (en) Substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
IL206765A0 (en) 4,5-dihydro-oxazol-2-yl-amine derivatives
IL201973A0 (en) 3,3-spiroindolinone derivatives
IL183568A (en) Process for making 7,8-dihydro-5 h-patridine-6-onh
ZA201001797B (en) 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
IL289379A (en) Citrate salt of 11-(2-pyrrolidin-1-yl-ethoxy)-19,14-dioxa-26,7,5-triaza-tetracyclo[1.1.3.19(6,2)1(12,8)]hepatacosa- 1(25),2(26),12,10,8,5,3(27)j23,21,16–Decan
IL188431A0 (en) Process for preparing 3-arylmethylthio-and 3-heteroarylmethylthio-4,5-dihydro-
EP2142542A4 (en) NEW IMIDAZO [4,5-B] PYRIDINE-7-CARBOXYLAMIDEAMIDE 704
ZA200706646B (en) Brown algae cell lyophilisate, method for the obtention thereof
PL2376500T3 (pl) Sól maleinianowa 11-(2-pirrolidyn-1-yloetoksy)-14,19-dioksa-5,7,26 triazatetracyklo[19.3.1.1(2,6).1(8,12)]heptakosa-1(25),2(26),3,5,8,10,12(27),16,21,23-dekaenu
IL206666A0 (en) N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-
PL2454266T3 (pl) Sól cytrynianowa 9E-15-(2-pirolidyn-1-ylo-etoksy)-7,12,25-trioksa-19,21,24-triaza-tetracyklo[18.3.1.1(2,5).1(14,18)]heksakoza-1(24),2,4,9,14,16,18(26),20,22-nonaenu
IL187673A0 (en) Process for preparing 3,3-diarylpropylamines
ZA200702070B (en) Process for preparing substituted 8-azablcyclo[3.2.1] octan-3-ols
TH0901005537B (th) 11-(2-ไพร์โรลิดิน-1-อิล-เอทอกซี)-14,19-ไดออกซา-5,7,26-ไตรอะซา-เตตราไซโคล[19.3.1.1(2,6).1(8,12)]เฮปทาโคซา-1(25),2(26),3,5,8,10,12(27),16,21,23-เดคาอีน มาลีเอท ซอลท์
IL188111A0 (en) 2,5-bis-diamimne [1,4] benzoquinone-derivatives
IL198203A0 (en) Process for preparing 5-alkyl-7h-pyrrolo[2,3-d]pyrimidine-2-ols
IL180493A (en) Process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
HK1122790A (en) Process for preparing 4,4'-difluorobenzophenone